Brief: Larimar Therapeutics- Gave Notice To Terminate Sales Agreement With Guggenheim Securities
Feb 14 (Reuters) - Larimar Therapeutics Inc LRMR.O :
* LARIMAR THERAPEUTICS: ON FEBRUARY 13, GAVE NOTICE TO
TERMINATE
SALES AGREEMENT THAT COMPANY ENTERED INTO WITH GUGGENHEIM
SECURITIES
Source text for Eikon: ID:n0000950170-24-014919
Further company coverage: LRMR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update